Zebin Zhu

1000 total citations · 1 hit paper
33 papers, 410 citations indexed

About

Zebin Zhu is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Zebin Zhu has authored 33 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 13 papers in Surgery and 10 papers in Epidemiology. Recurrent topics in Zebin Zhu's work include Liver Disease and Transplantation (13 papers), Organ Transplantation Techniques and Outcomes (10 papers) and Renal Transplantation Outcomes and Treatments (5 papers). Zebin Zhu is often cited by papers focused on Liver Disease and Transplantation (13 papers), Organ Transplantation Techniques and Outcomes (10 papers) and Renal Transplantation Outcomes and Treatments (5 papers). Zebin Zhu collaborates with scholars based in China, United States and Finland. Zebin Zhu's co-authors include Mengfan Wang, Chenglin Yan, Tao Qian, Yuanbo Zhou, Jianmei Lu, Najun Li, Lifang Zhang, Yunhua Tang, Yixi Zhang and Weiqiang Ju and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and Journal of Hazardous Materials.

In The Last Decade

Zebin Zhu

29 papers receiving 406 citations

Hit Papers

Optimizing Intermediate Adsorption over PdM (M=Fe, Co, Ni... 2024 2026 2025 2024 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zebin Zhu China 12 107 106 102 99 99 33 410
Yan Tian China 9 50 0.5× 51 0.5× 25 0.2× 75 0.8× 149 1.5× 19 487
Can Kong China 11 32 0.3× 33 0.3× 20 0.2× 152 1.5× 23 0.2× 23 431
Chih‐Yang Hsiao Taiwan 10 59 0.6× 96 0.9× 91 0.9× 14 0.1× 43 0.4× 25 299
Masafumi Ohira Japan 7 28 0.3× 109 1.0× 53 0.5× 19 0.2× 55 0.6× 18 252
Naoki Yamanaka Japan 11 69 0.6× 47 0.4× 31 0.3× 52 0.5× 54 0.5× 24 400
Yihe Liu China 9 47 0.4× 44 0.4× 36 0.4× 93 0.9× 3 0.0× 33 350
Yoshiki Inoue Japan 11 62 0.6× 15 0.1× 13 0.1× 94 0.9× 23 0.2× 33 449
Evanthia Kostopoulou Greece 14 145 1.4× 130 1.2× 34 0.3× 81 0.8× 1 0.0× 32 611
Xiaoxiao Liu China 13 23 0.2× 91 0.9× 2 0.0× 104 1.1× 58 0.6× 33 417

Countries citing papers authored by Zebin Zhu

Since Specialization
Citations

This map shows the geographic impact of Zebin Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zebin Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zebin Zhu more than expected).

Fields of papers citing papers by Zebin Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zebin Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zebin Zhu. The network helps show where Zebin Zhu may publish in the future.

Co-authorship network of co-authors of Zebin Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Zebin Zhu. A scholar is included among the top collaborators of Zebin Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zebin Zhu. Zebin Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fang, Jun, Tielong Wang, Kang He, et al.. (2025). Immune-related adverse events are a potent predictor of post-transplant rejection in HCC: a multicentre retrospective cohort study. Gut. gutjnl–2025. 1 indexed citations
2.
Zhang, Lifang, Mengfan Wang, Xiaowei Shen, et al.. (2025). Maximized atom utilization in a high-entropy metallene via single atom alloying for boosted nitrate electroreduction to ammonia. Nature Communications. 16(1). 7915–7915. 7 indexed citations
3.
Zhang, Shaobo, Zebin Zhu, Lianxin Liu, Björn Nashan, & Shugeng Zhang. (2025). Biomarker, efficacy and safety analysis of transcatheter arterial chemoembolization combined with atezolizumab and bevacizumab for unresectable hepatocellular carcinoma. Cancer Immunology Immunotherapy. 74(7). 209–209.
4.
Wang, Ning, Zebin Zhu, Hao Zheng, et al.. (2024). Diagnosis and Treatment of Hepatic Hematoma After Liver Transplantation in a Timely Manner. Transplantation Proceedings. 56(6). 1390–1395.
5.
Sun, Xiaoping, et al.. (2024). An evaluation of microplastic contamination in the marine waters and species in the coastal region of the South Yellow Sea, China. Journal of Hazardous Materials. 469. 134018–134018. 11 indexed citations
6.
Zhao, Qiang, Kunpeng Liu, Zebin Zhu, et al.. (2024). Activation of farnesoid X receptor enhances the efficacy of normothermic machine perfusion in ameliorating liver ischemia-reperfusion injury. American Journal of Transplantation. 24(9). 1610–1622. 2 indexed citations
7.
Zhu, Zebin, et al.. (2024). Liver Transplantation for Diffuse Form of Caroli Disease with Chronic Hepatitis B: A Case Report. Transplantation Proceedings. 56(5). 1161–1164. 1 indexed citations
8.
Zhou, Yuanbo, Lifang Zhang, Zebin Zhu, et al.. (2024). Optimizing Intermediate Adsorption over PdM (M=Fe, Co, Ni, Cu) Bimetallene for Boosted Nitrate Electroreduction to Ammonia. Angewandte Chemie. 136(18). 28 indexed citations
9.
Zhou, Yuanbo, Lifang Zhang, Zebin Zhu, et al.. (2024). Optimizing Intermediate Adsorption over PdM (M=Fe, Co, Ni, Cu) Bimetallene for Boosted Nitrate Electroreduction to Ammonia. Angewandte Chemie International Edition. 63(18). e202319029–e202319029. 80 indexed citations breakdown →
10.
11.
12.
Wang, Jizhou, Wei Wu, Dehao Huang, et al.. (2022). Incidence of Ischemia Reperfusion Injury Related Biliary Complications in Liver Transplantation: Effect of Different Types of Donors. Transplantation Proceedings. 54(7). 1865–1873. 6 indexed citations
13.
Zheng, Hao, Zhijun Xu, Wei Wu, et al.. (2021). Successful, Combined Long-term Treatment of Cerebral Candidiasis and Aspergillosis in a Liver Transplant Recipient: A Case Report. Transplantation Proceedings. 53(8). 2588–2593. 1 indexed citations
14.
Huang, Shanzhou�, Chengjun Sun, Zebin Zhu, et al.. (2020). Deceased Donor Predictors for Pediatric Liver Allograft Utilization. Transplantation Proceedings. 52(10). 2901–2908.
15.
Zhang, Yixi, Changjun Huang, Weiqiang Ju, et al.. (2020). Avoiding Ischemia Reperfusion Injury in Liver Transplantation. Journal of Visualized Experiments. 5 indexed citations
17.
Zhang, Yixi, Zebin Zhu, Shanzhou� Huang, et al.. (2019). lncRNA XIST regulates proliferation and migration of hepatocellular carcinoma cells by acting as miR-497-5p molecular sponge and targeting PDCD4. Cancer Cell International. 19(1). 198–198. 44 indexed citations
18.
Huang, Shanzhou�, Chengjun Sun, Yuchen Hou, et al.. (2018). A comprehensive bioinformatics analysis on multiple Gene Expression Omnibus datasets of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Scientific Reports. 8(1). 7630–7630. 32 indexed citations
19.
Zhu, Zebin, Yixi Zhang, Chen‐Song Huang, et al.. (2018). Overexpression of RALY promotes migration and predicts poor prognosis in hepatocellular carcinoma. Cancer Management and Research. Volume 10. 5559–5572. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026